TREA

97706107 - VERSÉA

Follow

Information

  • Trademark
  • 97706107
  • Serial Number
    97706107
  • Filing Date
    December 06, 2022
    3 years ago
  • Transaction Date
    May 21, 2025
    a year ago
  • Status Date
    May 19, 2025
    a year ago
  • Published for Opposition Date
    May 28, 2024
    2 years ago
  • Location Date
    November 19, 2024
    a year ago
  • Status Code
    730
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    CALLAGHAN, BRIAN
  • Attorney Docket Number
    1358734
    Attorney Name
    Olivia Maria Baratta
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
3
Mark Identification
VERSÉA
Case File Statements
  • DM0000: The mark consists of the word VERSÉA in a stylized font with an irregular trapezoid shape above it and a circle to the left of the irregular trapezoid shape.
  • GS0091: Downloadable mobile applications for use in telemedicine functionalities namely, remotely identifying and assessing health risks and the provision of information about products in the field of healthcare
  • GS0161: Product packaging in the nature of cardboard boxes, plastic and cardboard bags, sheets, and blister packs for packaging; perishables packaging, namely, packaging containers comprised of cardboard for food, beverages, and agricultural products; food packaging, namely, packaging containers comprised of cardboard for food and beverage products
  • GS0051: Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pregnancy testing preparations; ovulation test kits; pH test strips, namely, test strips for use in measuring the pH level in human bodies for purposes of determining levels of alkalinity in the body; diagnostic kits comprised of medical diagnostic test strips for use in disease detection, namely, urinary tract infection; diagnostic kits comprised of medical diagnostic test strips for use in the field of vaginal health; medical diagnostic test strips for use in the field of respiratory and infectious diseases; botanical therapeutic agents for promotion of general wellness; stem cells for medical purposes; pharmaceutical preparations for wounds; vitamins and dietary supplements; natural dietary supplements; dietary and nutritional supplements; mixed biological preparations for the prevention and treatment of infectious diseases; biological tissue cultures for medical purposes; biological bone or skin tissue intended for subsequent implantation; eye care, ophthalmology, and optometry products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, along with reader devices, sold together as a unit; pre-packaged laceration kits comprised of bandages for skin wounds, gauze, and materials to close lacerations; first-aid kits, filled
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Healthcare services; healthcare screenings and personalized medicine services
  • GS0101: Medical supplies, namely, sanitary masks for medical wellness purposes, medical gowns, medical apparel, namely, women's garment for use in medical examination and treatment, protective gloves for medical use, medical gloves, gloves for medical purposes, furniture especially made for medical purposes, bracelets for medical purposes, medical apparatus and instruments for monitoring vital signs, blood pressure, heart rate, medical syringes, containers especially adapted for the disposal of medical instruments, syringes and other contaminated medical waste, medical patient treatment chairs, medical ice packs, medical devices, namely, patient monitors and patient sensors for monitoring and measuring blood properties and respiratory events; diagnostic kits consisting primarily of probes, buffers, and reagents for use in disease and microbial testing; medical apparatus for testing blood samples and DNA and RNA samples
  • GS0421: Medical and scientific research; pharmaceutical research; research, testing, design, and development of pharmaceuticals; research, testing, design, and development of medical devices; research, testing, design, and development of biologics; research, testing, design, and development of product packaging; research, testing, design, and development of perishables packaging; research, testing, design, and development of food packaging; software as a service (SAAS) services, namely, providing a software platform that utilizes machine learning to assess and screen pharmaceutical drug candidates
  • GS0201: Product packaging in the nature of plastic shipping boxes; perishables packaging, namely, packaging containers of plastic for food, beverages, and agricultural products; food packaging, namely, packaging containers comprised of plastic for food and beverage products; plastic boxes for packaging products
Case File Event Statements
  • 6/13/2023 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/9/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 1/4/2023 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/5/2023 - 3 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/15/2023 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/15/2023 - 3 years ago
    6 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/15/2023 - 3 years ago
    7 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/30/2023 - 2 years ago
    8 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 9/12/2023 - 2 years ago
    9 - APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Type: XELR
  • 9/12/2023 - 2 years ago
    10 - APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Type: XELG
  • 12/13/2023 - 2 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/13/2023 - 2 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/14/2023 - 2 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/24/2024 - 2 years ago
    14 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/24/2024 - 2 years ago
    15 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 1/24/2024 - 2 years ago
    16 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/24/2024 - 2 years ago
    17 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/24/2024 - 2 years ago
    18 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/24/2024 - 2 years ago
    19 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/25/2024 - 2 years ago
    20 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/25/2024 - 2 years ago
    21 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/25/2024 - 2 years ago
    22 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/25/2024 - 2 years ago
    23 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/25/2024 - 2 years ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/8/2024 - 2 years ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 5/28/2024 - 2 years ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/26/2024 - 2 years ago
    28 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 11/19/2024 - a year ago
    30 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/28/2024 - 2 years ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/6/2024 - a year ago
    29 - EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Type: ETOP
  • 5/19/2025 - a year ago
    31 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/19/2025 - a year ago
    32 - SOU EXTENSION 1 FILED Type: EXT1
  • 5/20/2025 - a year ago
    33 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 5/20/2025 - a year ago
    34 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA